Apr 30, 2019
American Urological Association Releases Joint Clinical Guideline for Recurrent Urinary Tract Infections in Women with CUA and SUFU
Apr 26, 2019
Accelerate Diagnostics Schedules Call to Review First Quarter 2019 Results
Apr 16, 2019
FIU scientists discover new arsenic-based broad-spectrum antibiotic
Apr 04, 2019
Specific Diagnostics Announces the Appointment of Karen Koski as Chief Business Officer
Apr 03, 2019
Correvio Announces Xydalba(TM) (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019
Apr 01, 2019
Geom Therapeutics To Present Data From Antibiotic Drug Development Programs At ECCMID
Mar 29, 2019
Specific Diagnostics Begins Clinical Demonstrations and Testing of the Reveal AST System
Mar 28, 2019
Specific Diagnostics Achieves CARB-X Milestone and Advances Its Reveal Rapid Antibiotic Susceptibility Test For Life-Threatening Drug-Resistant Infections
Feb 26, 2019
Abstract on Nasal Photodisinfection Therapy is Accepted for Presentation at the 19th Annual Scientific Conference of the Canadian Spine Society
Feb 14, 2019
Tanabe Research Labs Announce FDA Acceptance of its IND Application for TR1801-ADC (MT-8633), an ADC Targeting cMet Positive Solid Tumors
Feb 05, 2019
Arrevus Finalizes Acquisition of Fusidic Acid (Taksta(TM)) from Melinta Therapeutics
Jan 07, 2019
Theravance Biopharma Announces Alignment of Workforce with Focus on Key Strategic Priorities
Nov 26, 2018
MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. for Novel Antibiotic, Contezolid Acefosamil
Nov 06, 2018
Theravance Biopharma, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
Nov 06, 2018
Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals
Oct 30, 2018
Antibiotics Market to Reach $50.37 Bn, Globally, by 2025 at 2.1% CAGR, Says Allied Market Research
Oct 30, 2018
Theravance Biopharma to Report Third Quarter 2018 Financial Results on November 6
Oct 22, 2018
Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections
Oct 12, 2018
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
Oct 11, 2018
Theravance Biopharma and Mylan Report Positive New Data from Multiple Studies of YUPELRI(TM) (revefenacin) at the 2018 CHEST Annual Meeting